E Briasoulis Selected Research

E Briasoulis Research Topics

Disease

25	Neoplasms (Cancer) 08/2015 - 01/2000
17	Breast Neoplasms (Breast Cancer) 11/2012 - 01/2000
5	Carcinoma (Carcinomatosis) 07/2008 - 09/2000
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011 - 03/2004
4	Neoplasm Metastasis (Metastasis) 07/2008 - 09/2000
4	Neutropenia 12/2007 - 01/2000
3	Melanoma (Melanoma, Malignant) 04/2012 - 01/2002
2	Febrile Neutropenia 12/2007 - 10/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2007 - 11/2005
2	Vomiting 05/2005 - 01/2002
2	Fatigue 01/2004 - 01/2002
2	Hypersensitivity (Allergy) 01/2002 - 07/2000
2	Pulmonary Edema 01/2001 - 01/2000
1	Hypoxia (Hypoxemia) 08/2015
1	Colorectal Neoplasms (Colorectal Cancer) 12/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2012
1	Lymphoma (Lymphomas) 10/2012
1	Thrombocytopenia (Thrombopenia) 05/2008
1	Ovarian Epithelial Carcinoma 09/2007
1	Ovarian Neoplasms (Ovarian Cancer) 01/2006
1	Diarrhea 02/2005
1	Exanthema (Rash) 02/2005
1	Mouth Neoplasms (Oral Cancer) 01/2005
1	Hyponatremia 01/2005
1	Inappropriate ADH Syndrome (SIADH) 01/2005
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2004
1	Anorexia 01/2004

Drug/Important Bio-Agent (IBA)

7	Paclitaxel (Taxol)FDA LinkGeneric 11/2012 - 09/2000
6	Proteins (Proteins, Gene)FDA Link 01/2012 - 09/2001
5	Irinotecan (Camptosar)FDA LinkGeneric 12/2012 - 09/2004
4	Docetaxel (Taxotere)FDA Link 11/2012 - 01/2000
4	ParaffinIBA 12/2008 - 04/2003
4	Cisplatin (Platino)FDA LinkGeneric 12/2007 - 05/2005
4	PlatinumIBA 01/2006 - 09/2003
3	Vinorelbine (Navelbine)FDA LinkGeneric 08/2015 - 09/2001
3	Biomarkers (Surrogate Marker)IBA 11/2012 - 04/2012
3	taxaneIBA 11/2012 - 05/2008
3	Estrogen ReceptorsIBA 01/2012 - 09/2001
3	AnthracyclinesIBA 05/2009 - 09/2001
3	Epirubicin (Ellence)FDA LinkGeneric 05/2008 - 10/2004
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2007 - 01/2000
3	beta-D-glucosylisophosphoramide mustard (glufosfamide)IBA 03/2004 - 10/2000
2	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 10/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012 - 01/2006
2	Taxoids (Taxanes)IBA 11/2012 - 07/2000
2	Messenger RNA (mRNA)IBA 04/2012 - 12/2008
2	Thrombospondin 1IBA 01/2012 - 01/2006
2	ErbB Receptors (EGF Receptor)IBA 01/2011 - 02/2005
2	Formaldehyde (Formol)FDA Link 12/2008 - 12/2004
2	Gefitinib (Iressa)FDA Link 12/2007 - 02/2005
2	Etoposide (VP 16)FDA LinkGeneric 12/2007 - 11/2005
2	MetallothioneinIBA 01/2006 - 04/2003
2	Carboplatin (JM8)FDA LinkGeneric 10/2004 - 09/2000
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2004 - 04/2003
2	Pharmaceutical PreparationsIBA 03/2004 - 01/2001
2	Interleukin-2 (IL2)IBA 01/2004 - 01/2001
2	CreatinineIBA 11/2003 - 10/2000
2	Cathepsin DIBA 04/2003 - 12/2002
2	Gemcitabine FDA Link 01/2001 - 01/2000
1	Bevacizumab (Avastin)FDA Link 12/2012
1	CollagenIBA 10/2012
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2012
1	Azacitidine (5 Azacytidine)FDA Link 04/2012
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2012
1	Tyrosine Kinase InhibitorsIBA 01/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2011
1	Trastuzumab (Herceptin)FDA Link 05/2009
1	thiamine triphosphorate (TTP)IBA 02/2009
1	RNA (Ribonucleic Acid)IBA 12/2008
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2008
1	Phosphotransferases (Kinase)IBA 12/2007
1	Carrier Proteins (Binding Protein)IBA 01/2006
1	MetalsIBA 01/2006
1	Methotrexate (Mexate)FDA LinkGeneric 11/2005
1	Fluorouracil (Carac)FDA LinkGeneric 11/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2005
1	Topotecan (Hycamtin)FDA LinkGeneric 05/2005
1	Vasopressins (Vasopressin)IBA 01/2005
1	StreptavidinIBA 12/2004
1	AvidinIBA 12/2004
1	Syndecan-1 (Syndecan 1)IBA 12/2004
1	Biotin (Vitamin H)FDA Link 12/2004
1	liposomal doxorubicin (Doxil)FDA Link 10/2004
1	Steroid Receptors (Steroid Receptor)IBA 05/2004
1	Biological ProductsIBA 05/2004
1	Superoxide DismutaseIBA 01/2004
1	AntibodiesIBA 01/2004
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2004
1	InterleukinsIBA 01/2004
1	Temozolomide (Temodar)FDA LinkGeneric 01/2004
1	EnzymesIBA 01/2004
1	Estrogen Receptor betaIBA 01/2004
1	Estrogen Receptor alphaIBA 01/2004

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 08/2015 - 01/2000
9	Therapeutics 08/2015 - 01/2000
4	Combination Drug Therapy (Combination Chemotherapy) 12/2007 - 09/2000
3	Adjuvant Chemotherapy 05/2009 - 03/2001
2	Radiotherapy 10/2003 - 01/2001
1	Cytoreduction Surgical Procedures 02/2009
1	Treatment Delay 10/2004